Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$8,414,139
-$13,536 QoQ
Shares Held
53,689
-2.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#190
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,414,139 | 53,689 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $8,427,675 | 55,173 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,521,801 | 47,304 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,994,593 | 54,543 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,380,856 | 52,730 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,624,524 | 41,483 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,192,364 | 53,359 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $4,260,225 | 37,039 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $3,775,816 | 35,467 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,742,783 | 18,017 | Shares | Other | 2024-05-28 | |
| 2023-12-31 | $3,208,422 | 31,776 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $3,049,688 | 29,940 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $2,794,197 | 27,690 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,547,480 | 27,690 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $2,730,671 | 30,100 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $134,723,846 | 1,772,449 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $387,512,398 | 4,584,318 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $404,542,856 | 4,610,175 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $409,132,439 | 4,677,403 | Shares | Other | 2022-02-04 | |
| 2021-09-30 | $358,568,415 | 4,384,549 | Shares | Other | 2021-11-05 | |
| 2021-06-30 | $574,790,100 | 6,299,760 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $500,961,606 | 5,860,571 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $571,408,676 | 6,051,135 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $545,976,618 | 6,278,480 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $581,031,356 | 6,652,523 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $271,492,842 | 3,292,818 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||